QSAR, docking studies and pharmacophore identification of phenylmethyl phenoxy propyl amino propanoic acid derivatives as leukotriene A4 hydrolase inhibitors.
- Author:
Lalit V SONAWANE
1
;
Sanjaykumar B BARI
Author Information
1. R. C. Patel Institute of Pharmaceutical Education and Research, Karwand Naka, Shirpur, Dist.--Dhule, Maharashtra State, 425405, India. lal303@rediffmail.com
- Publication Type:Journal Article
- MeSH:
Catalytic Domain;
Databases, Factual;
Enzyme Inhibitors;
chemical synthesis;
chemistry;
Epoxide Hydrolases;
antagonists & inhibitors;
Models, Molecular;
Molecular Structure;
Protein Binding;
Quantitative Structure-Activity Relationship;
Software;
beta-Alanine;
analogs & derivatives;
chemical synthesis;
chemistry
- From:
Acta Pharmaceutica Sinica
2010;45(5):615-623
- CountryChina
- Language:English
-
Abstract:
The enzyme leukotriene A4 (LTA4) plays an important role as precursor of slow reactive substances as LTC4, LTD4, and LTE4. It is an attractive target for molecular modeling and QSAR study. Our effort is mainly focused on exploring the SAR for inhibitors of the LTA4 hydrolase through docking study, pharmacophore modeling and molecular descriptor study. The binding of these small molecules on LTA4 hydrolase enzyme was described by the models developed on 2D molecular descriptors, with good predictive power (39 compounds, 6 descriptors, r2 0.98, SEE 0.167, F-value 268.53, q2 0.90, r2 adj 0.97, P-value < 0.0001, SD of residuals 0.15). Docking studies were employed to presume the probable binding conformation of these analogues and exploring the SAR for the compounds. The novel pharmacophore represents the ligand features that are involved in interactions with the target protein, as well as the space around the ligand occupied by the protein. The efforts are aimed to discover the SAR for the inhibitors of LTA4 hydrolase through techniques of QSAR, docking and pharmacophore.
